St. Louis, MO, March 4, 2011 — The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors. In a study scheduled for publication in the April issue of the Archives of Physical Medic…
New findings on how tuberculosis (TB) bacteria develop multi-drug tolerance point to ways TB infections might be cured more quickly.
The study will be published April 1 in the journal Cell. The results identify both a mechanism and a potenti…
LEBANON, NH – A clinical study of anti-HIV/AIDS medicines in the developing world is on the verge of turning “the whole treatment world on its head,” according to Dartmouth pediatrician Paul Palumbo.
Palumbo, a professor of pediatric medicine at D…
Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries — and ancient wisdom suggests that it’s also good for your health. Taking this wisdom to the laboratory, Tel Aviv University r…
Indiana University scientists have solved a perplexing mystery regarding one of the body’s main energy storage molecules, in the process shedding light on a possible route to treatment of a rare but deadly disease in teenagers.
The disease occur…
Researchers at Karolinska Institutet have shown in a new study on mice, that cell therapy can be used to reverse the effect of ‘bad’ LDL cholesterol and reduce the inflammation that leads to atherosclerosis. The new cell therapy, which is presented …
The 18th Conference on Retroviruses and Opportunistic Infections is taking place at the Hynes Convention Center in Boston from February 27 through March 2. Day two of this major HIV/AIDS research conference included the following selected presenta…
Researchers from Spain have identified a strain of probiotic bacteria that may be useful in treating ulcers caused by Helicobacter pylori. They report their findings in the February 2011 issue of the journal Applied and Environmental Microbiology.
…
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans ha…
Nanotechnology may open a new door on the treatment of liver cancer, according to a team of Penn State College of Medicine researchers. They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death i…
A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity.
The results of a multicenter clinical trial…
The first study of its kind in the world — involving 336 children aged between six months and 16 years old — has shown that installing a water softener for three months brings no additional relief for eczema sufferers.
Up to one fifth of all…
SCOTTSDALE, Ariz. — Feb. 16, 2011 — Whole genome sequencing — spelling out a person’s entire DNA genetic code — has moved one step closer to being a medical option for direct patient care.
Physicians and researchers at Mayo Clinic in A…
DALLAS — Feb. 15, 2011 — Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exp…
(Santa Barbara, Calif.) — – UC Santa Barbara scientists have made a discovery that has the potential for use in the early diagnosis and eventual treatment of plaque-related diseases such as Alzheimer’s disease and Type 2 diabetes. Their work …
After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding int…
Older individuals, who constitute a rapidly growing population in the United States, account for a disproportionate share of health care utilization and cost.
Yet more than half of clinical trials exclude people based on their age or age-related …
CHICAGO — A hip fracture is not common in a 54-year-old woman, unless she is a 54-year-old breast cancer survivor, according to a new Northwestern Medicine study. Researchers found that a combination of early menopause due to breast cancer treatme…
